XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenue $ 9,265,000 $ 4,843,000 $ 1,384,000
Cost of revenue 5,833,000 2,741,000 815,000
Gross profit 3,432,000 2,102,000 569,000
Research and development expenses 74,768,000 20,497,000 15,406,000
General and administrative expenses 28,407,000 5,664,000 4,290,000
Selling and marketing expenses 4,443,000 1,682,000 966,000
Total operating expenses 107,618,000 27,843,000 20,662,000
Operating loss (104,186,000) (25,741,000) (20,093,000)
Interest income 372,000 195,000 516,000
Other income (expense), net 1,936,000 (24,000) (17,000)
Loss before income taxes (101,878,000) (25,570,000) (19,594,000)
Income taxes 0 0 0
Net loss (101,878,000) (25,570,000) (19,594,000)
Unrealized loss on available-for-sale securities (524,000) 0 0
Total comprehensive loss $ (102,402,000) $ (25,570,000) $ (19,594,000)
Net loss attributable per share to common stockholders:      
Net loss per share, basis and diluted $ (0.51) $ (0.18) $ (0.17)
Weighted-average shares used in computing net loss per share attributable to common stockholders:      
Weighted-average shares used in computing net loss per share, basic and diluted 200,849,663 141,741,752 114,967,922
Product [Member]      
Revenue $ 1,776,000 $ 1,534,000 $ 819,000
Cost of revenue 1,365,000 717,000 563,000
Professional Service [Member]      
Revenue 7,489,000 3,309,000 565,000
Cost of revenue $ 4,468,000 $ 2,024,000 $ 252,000